1. Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy
   TAKUMI OCHIAI et al, 2014, Molecular and Clinical Oncology CrossRef
2. Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs
   TAKUMI OCHIAI et al, 2013, Molecular and Clinical Oncology CrossRef
3. Impact of low serum iron on treatment outcome of PD-1 inhibitors in advanced gastric cancer
   Yu Yang et al, 2023, BMC Cancer CrossRef